Hypertension Trial, Recruiting NCT05845905 Sponsor: Yi Yang Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT05845905
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 65 to 85 years old, of any gender.
  • People who have been diagnosed with essential (primary) hypertension and whose measured systolic blood pressure (the top number) is 140 mmHg or higher, whether or not they are currently taking blood pressure medication.
  • People who are willing to take part and sign a consent form agreeing to participate.

Who may not be able to join:

  • People whose high blood pressure is caused by another underlying medical condition (known as secondary hypertension).
  • People whose measured blood pressure is 180/110 mmHg or higher, or whose average blood pressure over 24 hours is 170/100 mmHg or higher.
  • People who have severe problems with how a major organ (such as the heart, kidneys, or liver) is functioning.
  • People who have serious blood disorders or significant problems with blood clotting.
  • People who have a history of atrial fibrillation (an irregular heart rhythm) or who have had a heart attack within the past 6 months.
  • People who have conditions that would make a procedure called remote ischemic conditioning unsafe — for example, serious injury, fracture, or blood vessel damage in the upper arm, certain blood clot conditions, blocked arteries in the limbs, or a condition called subclavian steal syndrome (confirm with trial site).
  • People who are currently taking, or are planned to take, blood-thinning medications such as dabigatran, rivaroxaban, or warfarin.
  • People who are currently in another clinical trial, or who have taken part in another clinical trial within the past 3 months, or who have previously taken part in this specific study.
  • People whom the research team considers unsuitable for the trial for other reasons (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13756661217

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Yi Yang
Registry
ClinicalTrials.gov
Start date
10 May 2023
Est. completion
31 December 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Mean systolic blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov